Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Sequence Analysis, RNA × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Nevi and Melanomas 1 Neoplasms, Unknown Primary 1 Melanoma 1 Genetic Predisposition to Disease 1 Disease 1 Breast Neoplasms 1

Interventions

Carboplatin 10 Paclitaxel 9 Gemcitabine 9 Capecitabine 7 Irinotecan 6 Fluorouracil 5 Radiotherapy 4 Oxaliplatin 4 Leucovorin 4 Cisplatin 4 Filgrastim 3 Etoposide 3 Cyclophosphamide 3 pembrolizumab 2 etoposide phosphate 2 Trastuzumab 2 Topotecan 2 Surveys and Questionnaires 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Genetic Testing 2 FAPI-46 2 Docetaxel 2 CP protocol 2 Bevacizumab 2 Amifostine 2 Albumin-Bound Paclitaxel 2 zenocutuzumab 1 tipifarnib 1 tegafur-gimeracil-oteracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366008 2026-01-26

NorCUP

Haukeland University Hospital

Phase NA Not yet recruiting

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡